← Back to Treatments
🏅 FDA Orphan Designation

So-Aqueous

sotalol (IV)

Manufacturer: AltaThera Pharmaceuticals LLC

Indicated for:
Catecholaminergic polymorphic ventricular tachycardiaOrphanHereditary atrial fibrillation

FDA-Approved Indications (2)

For use as a substitute for oral sotalol in patients who are unable to take sotalol orally [oral sotalol is indicated for maintenance of normal sinus rhythm in patients with history of highly symptoma…

maintenance of normal sinus rhythm in patients with history of highly symptomatic atrial fibrillation/flutter

Population: patients unable to take sotalol orally

Indications & Usage

For use as a substitute for oral sotalol in patients who are unable to take sotalol orally [oral sotalol is indicated for maintenance of normal sinus rhythm in patients with history of highly symptomatic atrial fibrillation /flutter, and for treatment of documented life-threatening ventricular arrhythmias]

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.